Prevalence of HF in Asia From GBD 1990 to 2019
(A) ASR of HF prevalence among 5 Asian GBD (Global Burden of Disease) data regions from 1990 to 2019. 3 showed a decrease in the ASR of HF from 1990 to 2019, with the largest decreases being in high-income Asia Pacific (22.10%), followed by Central Asia (6.56%) and East Asia (4.36%). Only 2 GBD regions in Asia showed an increased trend, with the Southeast Asia (3.68%) and South Asia (4.22%). (B) Unstandardized prevalence of HF in 5 Asian GBD regions from 1990 to 2019. The absolute numbers of HF prevalent cases among all Asian regions have increased from 1990 to 2019 (from 33% increase in Central Asia to 186% increase in East Asia). Abbreviations as in Figure 1.